Antiinfectives and low-level light: A new chapter in photomedicine

Photomedicine and Laser Surgery

Volumn 25, Issue 3, 2007, Pages 150-158

  Sommer, Andrei P ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENTS; DRUG CONCENTRATION; LOW-LEVEL LIGHT (LLL) THERAPY; NANOSUSPENSION DROPS; PHOTOMEDICINE;

ANTIBIOTICS; BIOLOGICAL SYSTEMS; DRUG DELIVERY; LIGHT TRANSMISSION; MICROORGANISMS; OPTICS;

BIOMEDICAL ENGINEERING;

ANTIINFECTIVE AGENT; CHLORAMPHENICOL; GENTAMICIN; METRONIDAZOLE; NYSTATIN; SULFADIMIDINE; WATER;

ARTICLE; BACTERIAL GROWTH; FILM; GROWTH INHIBITION; IMMUNOMODULATION; LIGHT INTENSITY; LOW LEVEL LASER THERAPY; PHOTOSTIMULATION; SUPPOSITORY; THICKNESS; VAGINITIS; WOUND HEALING;

ANTI-INFECTIVE AGENTS; BIOPHYSICS; COMBINED MODALITY THERAPY; DIABETIC NEUROPATHIES; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; LYMPHOCYTES; NANOMEDICINE; VAGINOSIS, BACTERIAL; WOUND HEALING;

EID: 34447559718     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2007.2058     Document Type: Article

References (49)

1. Brown, E.D. (2006). Microbiology: Antibiotic stops "ping-pong" match. Nature 441, 293-294.
2. Taylor, P.W., and Sommer, A.P. (2005). Towards rational treatment of bacterial infections during extended space travel. Int. J. Antimicrob. Agents 26, 183-187.
3. Tegos, G.P., and Hamblin, M.R. (2006). Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob. Agents Chemother. 50, 196-203.
4. Mester, E., Mester, A.F., and Mester, A. (1985). The biomedical effects of laser application. Lasers Surg. Med. 5, 31-39.
5. Mester, E. (1966). The use of the laser beam in therapy. Orv. Hetil. 107, 1012-1016.
6. Maiman, T.H. (1960). Stimulated optical radiation in ruby. Nature 187, 493-494.
7. Mester, A.R., Nagylucskay, S., and Mako, E.K. (2001). Nonthermal biological effects of radiology-based laser irradiation. J. Clin. Laser. Med. Surg. 19, 110.
8. Sommer, A.P. (1993). Fast surface covering beam distributor for lasers. German Patent and Trademark Office, DE4308474C2 (2001).
9. th Congress of the European Society for Photobiology, Marburg, Germany.
10. Sommer, A.P., Pinheiro, A.L.B., Mester, A.R., et al. (2001). Biostimulatory windows in low-intensity laser activation: lasers, scanners and NASA's light emitting diode array system. J. Clin. Laser Med. Surg. 19, 29-33.
11. st International Conference on Nearfield Optical Analysis. (2001). J. Clin. Laser Med. Surg. 19, 109-112.
12. nd International Conference on Nearfield Optical Analysis: Photodynamic Therapy & Photobiology Effects. (2001). NASA Publ. CP-2002-210786.
13. rd International Conference on Nearfield Optical Analysis. (2002). J. Clin. Laser Med. Surg. 20, 279-291.
14. Sommer, A.P., Oron, U., Pretorius, A.M., et al. (2003). A preliminary investigation into light-modulated replication of nanobacteria and heart disease. J. Clin. Laser Med. Surg. 21, 231-235.
15. Sommer, A.P., and Franke, R.P. (2006). Plants grow better if seeds see green. Naturwissenschaften 93, 334-337.
16. Sommer, A.P. (2003). Peripheral neuropathy and light - preliminary report indicating prevalence of nanobacteria in HIV. J. Proteome Res. 2, 665-666.
17. Sommer, A.P., Oron, U., Kajander, E.O., et al. (2002). Stressed cells survive better with light. J. Proteome Res. 1, 475.
18. Jelic, T.M., Malas, A.M., Groves, S.S., et al. (2004). Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med. J. 97, 194-198.
19. Miller, V.M., Rodgers, G., Charlesworth, J.A., et al. (2004). Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am. J. Physiol. Heart Circ. Physiol. 287, H1115-H1124.
20. Pretorius, A.M., Sommer, A.P., Aho, K.M., et al. (2004). HIV and nanobacteria. HIV Med. 5, 391-393.
21. Sommer, A.P. (2004). Could reduced bone mineral densities in HIV be caused by nanobacteria? J. Proteome Res. 3, 670-672.
22. Rao, N. (2005). Anti-infective therapy for foot ulcers in patients with diabetes. Clin. Orthop. Relat. Res. 439, 87-90.
23. Abdulrazak, A., Bitar, Z.I., Al-Shamali, A.A., et al. (2005). Bacteriological study of diabetic foot infections. J. Diabetes Compl. 19, 138-141.
24. Candel Gonzalez, F.J., Alramadan, M., Matesanz, M., et al. (2003). Infections in diabetic foot ulcers. Eur. J. Intern. Med. 14, 341-343.
25. Chincholikar, D.A., and Pal, R.B. (2002). Study of fungal and bacterial infections of the diabetic foot. Ind. J. Pathol. Microbiol. 45, 15-22.
26. Gerding, D.N. (1995). Foot infections in diabetic patients: the role of anaerobes. Clin. Infect. Dis. 20, S283-S288.
27. Louie, T.J., Bartlett, J.G., Tally, F.P., et al. (1976). Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann. Intern. Med. 85, 461-463.
28. Fredricks, D.N., Fiedler, T.L., and Marrazzo, J.M. (2005). Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899-1911.
29. Culligan, P., Heit, M., Blackwell, L., et al. (2003). Bacterial colony counts during vaginal surgery. Infect. Dis. Obstet. Gynecol. 11, 161-165.
30. Sommer, A.P., and Franke, R.P. (2002). Near-field optical analysis of living cells in vitro. J. Proteome Res. 1, 111-114.
31. Sommer, A.P., and Franke, R.P. (2003). Modulating the profile of nanoscopic water films with low level laser light. NanoLett. 3, 19-20.
32. Sommer, A.P. (2005). Controlling arrangement of 60 nm nanospheres in evaporating sessile drops with low level laser light. Cryst. Growth Des. 5, 559-563.
33. Jinesh, K.B., and Frenken, J.W.M. (2006). Capillary condensation in atomic scale friction: how water acts like a glue. Phys. Rev. Lett. 96, 166103.
34. Sommer, A.P. (2005). Method for improved uptake of antiinfectives by microorganisms. German Patent and Trademark Office, DE102005045654.5-54.
35. Milankovits, M. (2005). Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients. U.S. Patent and Trademark Office, US20050208152A1.
36. Sommer, A.P., and Gente, M. (2006). Biomimetics: from teeth to photonic crystal solar light collectors. Energy Fuels 20, 2189-2191.
37. Shoskes, D.A., Thomas, K.D., and Gomez, E. (2005). Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J. Urol. 173, 474-477.
38. Björklund, M., Ciftcioglu, N., and Kajander, E.O. (1998). Extraordinary survival of nanobacteria under extreme conditions. Proc. SPIE 3441, 123-129.
39. Kajander, E.O., and Ciftcioglu, N. (1998). Nanobacteria as extremophiles. Proc. SPIE 3755, 106-112.
40. Sommer, A.P., and Gheorghiu, E. (2006). Proteobionics: biomimetics in proteomics. J. Proteome Res. 5, 611-618.
41. Sommer, A.P., Pretorius, A.M., Kajander, E.O., et al. (2004). Biomineralization induced by stressed nanobacteria. Cryst. Growth Des. 4, 45-46.
42. Kajander, O.E., and Ciftcioglu, N. (2004). Methods for eradication of nanobacteria. U.S. Patent and Trademark Office, US6706290.
43. Wainwright, M., Wickramasinghe, N.C., Narlikar, J.V., et al. (2004). Are these stratospheric nanoparticles bacteria? Microbiology 150, 756-758.
44. Sommer, A.P., Cehreli, M., Akca, K., et al. (2005). Superadhesion: attachment of nanobacteria to tissues - model simulation. Cryst. Growth Des. 5, 21-23.
45. Sommer, A.P., Milankovits, M., and Mester, A.R. (2006). Nanobacteria, HIV and magic bullets: update of perspectives 2005. Chemotherapy 52, 95-97.
46. Kolter, R., and Greenberg, E.P. (2006). The superficial life of microbes. Nature 441, 300-302.
47. Kajander, E.O. (2006). Nanobacteria - propagating calcifying nanoparticles. Lett. Appl. Microbiol. 42, 549-552.
48. Chukwu, G.A., Adeleke, O.A., Danfillo, I.S., et al. (2004). Dental caries and extractions of permanent teeth in Jos, Nigeria. Afr. J. Oral Health 1, 31-36.
49. Long, T.C., Saleh, N., Tilton, R.D., et al. (2006). Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 40, 4346-4352.